Showing results (1-10 of 461) with videos related to
Sort By:
Pageof 47
Pharmacology & Therapeutics|August 17, 2002
Cardiovascular effects of cannabinoidsMichael D Randall, David Harris, David A Kendall, et al.Life Sciences|October 2, 2002
Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular functionVera Ralevic, David A Kendall, Michael D Randall, et al.Current Vascular Pharmacology|January 20, 2009
Cannabinoid modulation of perivascular sympathetic and sensory neurotransmissionVera Ralevic, David A KendallEuropean Journal of Pharmacology|June 14, 2002
Cannabinoids inhibit pre- and postjunctionally sympathetic neurotransmission in rat mesenteric arteriesVera Ralevic, David A KendallThe Journal of Pharmacology and Experimental Therapeutics|June 19, 2004
Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bedMarnie Duncan, David A Kendall, Vera RalevicThe Journal of Physiology|March 19, 2002
Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bedDavid Harris, Audrey I McCulloch, David A Kendall, et al.British Journal of Pharmacology|May 8, 2004
The complexities of the cardiovascular actions of cannabinoidsMichael D Randall, David A Kendall, Saoirse O'SullivanBritish Journal of Pharmacology|May 19, 2004
Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptorMarnie Duncan, Paul Millns, Darren Smart, et al.Biochemical Pharmacology|December 6, 2020
History of Geoff Burnstock's research on P2 receptorsVera RalevicEuropean Journal of Pharmacology|September 13, 2003
Mechanisms of vasorelaxation to 17beta-oestradiol in rat arteriesPatcharin Tep-areenan, David A Kendall, Michael D RandallPageof 47